François Paye

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Jean‐Robert Delpéro · 7 shared papers, 2014–2021 · strength 0.44
   • Paper Acute Pancreatitis as the Initial Presentation of Pancreatic Adenocarcinoma does not Impact Short- and Long-term Outcom… DOI 10.1007/s00268-021-06205-1↗
   • Paper Severe postoperative complications decrease overall and disease free survival in pancreatic ductal adenocarcinoma after… DOI 10.1016/j.ejso.2018.03.024↗
   • Paper Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two differ… DOI 10.1016/j.ejso.2017.06.011↗
2. Alain Sauvanet · 9 shared papers, 2012–2021 · strength 0.43
   • Paper Acute Pancreatitis as the Initial Presentation of Pancreatic Adenocarcinoma does not Impact Short- and Long-term Outcom… DOI 10.1007/s00268-021-06205-1↗
   • Paper Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two differ… DOI 10.1016/j.ejso.2017.06.011↗
   • Paper Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pan… DOI 10.1016/j.jamcollsurg.2015.03.058↗
3. Thierry André · 6 shared papers, 2012–2021 · strength 0.34
   • Paper Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mut… DOI 10.1177/17588359211053412↗
   • Paper [Is it necessary to perform a surgery after neo-adjuvant treatment for initially borderline or locally advanced pancrea… DOI 10.1016/s0007-4551(15)31229-7↗
   • Paper Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinoma. DOI 10.1158/1078-0432.ccr-14-0667↗
4. Philippe Bachellier · 5 shared papers, 2014–2021 · strength 0.32
   • Paper Acute Pancreatitis as the Initial Presentation of Pancreatic Adenocarcinoma does not Impact Short- and Long-term Outcom… DOI 10.1007/s00268-021-06205-1↗
   • Paper Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two differ… DOI 10.1016/j.ejso.2017.06.011↗
   • Paper Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pan… DOI 10.1016/j.jamcollsurg.2015.03.058↗
5. Magali Svrcek · 6 shared papers, 2012–2021 · strength 0.27
   • Paper Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mut… DOI 10.1177/17588359211053412↗
   • Paper Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinoma. DOI 10.1158/1078-0432.ccr-14-0667↗
   • Paper Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma. DOI 10.1016/j.ejso.2013.07.089↗
6. Pascal R. Hammel · 5 shared papers, 2012–2021 · strength 0.24
   • Paper Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mut… DOI 10.1177/17588359211053412↗
   • Paper Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinoma. DOI 10.1158/1078-0432.ccr-14-0667↗
   • Paper S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma. DOI 10.1016/j.ejca.2013.04.017↗
7. Mustapha Adham · 3 shared papers, 2015–2021 · strength 0.23
   • Paper Acute Pancreatitis as the Initial Presentation of Pancreatic Adenocarcinoma does not Impact Short- and Long-term Outcom… DOI 10.1007/s00268-021-06205-1↗
   • Paper Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two differ… DOI 10.1016/j.ejso.2017.06.011↗
   • Paper Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pan… DOI 10.1016/j.jamcollsurg.2015.03.058↗
8. L. Chiche · 4 shared papers, 2015–2018 · strength 0.23
   • Paper Severe postoperative complications decrease overall and disease free survival in pancreatic ductal adenocarcinoma after… DOI 10.1016/j.ejso.2018.03.024↗
   • Paper Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two differ… DOI 10.1016/j.ejso.2017.06.011↗
   • Paper Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pan… DOI 10.1016/j.jamcollsurg.2015.03.058↗
9. Olivıer Turrini · 4 shared papers, 2014–2018 · strength 0.22
   • Paper Severe postoperative complications decrease overall and disease free survival in pancreatic ductal adenocarcinoma after… DOI 10.1016/j.ejso.2018.03.024↗
   • Paper Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two differ… DOI 10.1016/j.ejso.2017.06.011↗
   • Paper Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection st… DOI 10.1245/s10434-014-4304-3↗
10. Jerome F. Cros · 3 shared papers, 2013–2021 · strength 0.19
    • Paper Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mut… DOI 10.1177/17588359211053412↗
    • Paper Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinoma. DOI 10.1158/1078-0432.ccr-14-0667↗
    • Paper S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma. DOI 10.1016/j.ejca.2013.04.017↗
11. António Sá Cunha · 3 shared papers, 2015–2018 · strength 0.18
    • Paper Severe postoperative complications decrease overall and disease free survival in pancreatic ductal adenocarcinoma after… DOI 10.1016/j.ejso.2018.03.024↗
    • Paper Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pan… DOI 10.1016/j.jamcollsurg.2015.03.058↗
    • Paper Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection st… DOI 10.1245/s10434-014-4304-3↗
12. Renato Micelli Lupinacci · 2 shared papers, 2013–2021 · strength 0.16
    • Paper Acute Pancreatitis as the Initial Presentation of Pancreatic Adenocarcinoma does not Impact Short- and Long-term Outcom… DOI 10.1007/s00268-021-06205-1↗
    • Paper Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma. DOI 10.1016/j.ejso.2013.07.089↗
13. Jean‐Baptiste Bachet · 5 shared papers, 2012–2015 · strength 0.15
    • Paper Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinoma. DOI 10.1158/1078-0432.ccr-14-0667↗
    • Paper Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma. DOI 10.1016/j.ejso.2013.07.089↗
    • Paper S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma. DOI 10.1016/j.ejca.2013.04.017↗
14. Jean‐Marie Boher · 3 shared papers, 2014–2015 · strength 0.14
    • Paper Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pan… DOI 10.1016/j.jamcollsurg.2015.03.058↗
    • Paper Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection st… DOI 10.1245/s10434-014-4304-3↗
    • Paper Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection … DOI 10.1111/hpb.12061↗
15. Alice de Malet · 1 shared paper, 2021 · strength 0.12
    • Paper Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mut… DOI 10.1177/17588359211053412↗
16. Safi Dokmak · 1 shared paper, 2021 · strength 0.12
    • Paper Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mut… DOI 10.1177/17588359211053412↗
17. Louis de Mestier · 1 shared paper, 2021 · strength 0.12
    • Paper Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mut… DOI 10.1177/17588359211053412↗
18. Raphaël Maréchal · 4 shared papers, 2012–2015 · strength 0.11
    • Paper Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinoma. DOI 10.1158/1078-0432.ccr-14-0667↗
    • Paper S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma. DOI 10.1016/j.ejca.2013.04.017↗
    • Paper Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in res… DOI 10.1093/annonc/mdr617↗
19. Pieter Demetter · 4 shared papers, 2012–2015 · strength 0.11
    • Paper Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinoma. DOI 10.1158/1078-0432.ccr-14-0667↗
    • Paper S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma. DOI 10.1016/j.ejca.2013.04.017↗
    • Paper Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in res… DOI 10.1093/annonc/mdr617↗
20. Jean‐Luc Van Laethem · 4 shared papers, 2012–2015 · strength 0.11
    • Paper Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinoma. DOI 10.1158/1078-0432.ccr-14-0667↗
    • Paper S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma. DOI 10.1016/j.ejca.2013.04.017↗
    • Paper Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in res… DOI 10.1093/annonc/mdr617↗
21. Christophe Louvet · 4 shared papers, 2012–2015 · strength 0.11
    • Paper Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinoma. DOI 10.1158/1078-0432.ccr-14-0667↗
    • Paper S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma. DOI 10.1016/j.ejca.2013.04.017↗
    • Paper Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in res… DOI 10.1093/annonc/mdr617↗
22. Jean Lubrano · 1 shared paper, 2018 · strength 0.08
    • Paper Severe postoperative complications decrease overall and disease free survival in pancreatic ductal adenocarcinoma after… DOI 10.1016/j.ejso.2018.03.024↗
23. Jean Closset · 3 shared papers, 2012–2013 · strength 0.07
    • Paper S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma. DOI 10.1016/j.ejca.2013.04.017↗
    • Paper Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in res… DOI 10.1093/annonc/mdr617↗
    • Paper Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for… DOI 10.1053/j.gastro.2012.06.006↗
24. Pauline Duconseil · 1 shared paper, 2017 · strength 0.06
    • Paper Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two differ… DOI 10.1016/j.ejso.2017.06.011↗
25. Julie Périnel · 1 shared paper, 2017 · strength 0.06
    • Paper Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two differ… DOI 10.1016/j.ejso.2017.06.011↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.